Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity.
- Conditions
- myelophathyStroke10028037cerebrovascular accident / Spinal cord injury
- Registration Number
- NL-OMON48057
- Lead Sponsor
- Stichting Sint Maartenskliniek
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
- a minimum of 6 months post-lesion/post-stroke to ensure that the participant
has a stable neurological condition, without clinical alterations
- age 18 years or older at the time of the study
- spasticity of any/all of the m. triceps surae, i.e. have a MAS/Tardieu score
* 1
- have an ankle joint range of motion of at least 20° in the sagittal plane
- ability to make a transfer on to the Achilles (medical device)
- current treatment of any/all of the m. tricpes surae with BoNT-A for
spasticity reduction
Exclusion Criteria
- have a MAS/Tardieu score of 4
- receive BoNT-A combined with other therapies aimed at reducing spasticity
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary study parameter is the reflexive joint resistance measured across 3<br /><br>sessions.</p><br>
- Secondary Outcome Measures
Name Time Method <p>The secundary study parameters are the reflexive and intrinsic joint resistance<br /><br>measured across 3 sessions.</p><br>